Grove Bank & Trust Laboratory Corp Of America Holdings Transaction History

Grove Bank & Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$209.01 - $232.56 $485,530 - $540,236	2,323 Added 1374.56%	2,492 $544,000
Q3 2023 Oct 30, 2023	SELL	$201.05 - $221.7 $804 - $886	-4 Reduced 2.31%	169 $33,000
Q4 2022 Feb 03, 2023	BUY	$203.72 - $248.97 $35,243 - $43,071	173 New	173 $41,000
Q1 2018 May 07, 2018	SELL	$161.53 - $178.11 $200,297 - $220,856	-1,240 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$147.99 - $163.95 $14,946 - $16,558	-101 Reduced 7.53%	1,240 $198,000
Q3 2017 Nov 13, 2017	BUY	$149.47 - $160.56 $200,439 - $215,310	1,341	1,341 $202,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Grove Bank & Trust with notifications on news.